Literature DB >> 17478888

Progesterone derivatives increase expression of Krox-20 and Sox-10 in rat Schwann cells.

Valerio Magnaghi1, Marinella Ballabio, Ilaria Roglio, Roberto C Melcangi.   

Abstract

Neuroactive steroids, like progesterone (P) and its 5alpha-reduced derivatives dihydroprogesterone (DHP) and tetrahydroprogesterone (THP), are involved in the control of Schwann cell proliferation and in the myelinating program of these cells. Here, we demonstrate that in culture of rat Schwann cells, P and its derivatives also increase expression of Sox-10 and Krox-20 (i.e., two transcription factors with a key role in Schwann cell physiology and in their myelinating program). Data obtained by quantitative RT-PCR analysis show that treatment with P, DHP, or THP increases mRNA levels of Krox-20. This stimulatory effect anticipates that exerted by P and DHP on Sox-10 gene expression. Thus, although the effect on Krox-20 occurs after 1 h, that on Sox-10 reaches a peak after 2 h. A similar pattern of effect is also evident on their protein levels. As evaluated by Western blot analysis, Krox-20 is increased after 3 h of treatment with P, DHP, or THP, whereas P or DHP stimulates the expression of Sox-10 after 6 h of exposure. A computer analysis performed on rat and human promoters of these two transcription factors shows that putative P-responsive elements are present in Krox-20 but not in Sox-10. Interestingly, many putative binding sites for Krox-20 are present in the Sox-10 promoter. The observations reported here, together with the concept that P and its derivatives are able to influence directly the expression of myelin proteins, suggest that these neuroactive steroids might coordinate the Schwann cell-myelinating program utilizing different intracellular pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478888     DOI: 10.1385/jmn/31:02:149

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  45 in total

1.  The TRANSFAC system on gene expression regulation.

Authors:  E Wingender; X Chen; E Fricke; R Geffers; R Hehl; I Liebich; M Krull; V Matys; H Michael; R Ohnhäuser; M Prüss; F Schacherer; S Thiele; S Urbach
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 2.  Formation and effects of neuroactive steroids in the central and peripheral nervous system.

Authors:  R C Melcangi; V Magnaghi; M Galbiati; L Martini
Journal:  Int Rev Neurobiol       Date:  2001       Impact factor: 3.230

3.  GABAB receptors in Schwann cells influence proliferation and myelin protein expression.

Authors:  Valerio Magnaghi; Marinella Ballabio; Ilaria T R Cavarretta; Wolfgang Froestl; Jeremy J Lambert; Ileana Zucchi; Roberto C Melcangi
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

4.  Early activation of transcription factor expression in Schwann cells by progesterone.

Authors:  G Mercier; N Turque; M Schumacher
Journal:  Brain Res Mol Brain Res       Date:  2001-12-30

5.  Down-regulation of Cdc6, a cell cycle regulatory gene, in prostate cancer.

Authors:  Liza D Robles; Andra R Frost; Monica Davila; Alan D Hutson; William E Grizzle; Ratna Chakrabarti
Journal:  J Biol Chem       Date:  2002-05-02       Impact factor: 5.157

Review 6.  Progesterone synthesis and myelin formation in peripheral nerves.

Authors:  M Schumacher; R Guennoun; G Mercier; F Désarnaud; P Lacor; J Bénavides; B Ferzaz; F Robert; E E Baulieu
Journal:  Brain Res Brain Res Rev       Date:  2001-11

7.  Glucocorticosteroids stimulate the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells.

Authors:  F Désarnaud; S Bidichandani; P I Patel; E E Baulieu; M Schumacher
Journal:  Brain Res       Date:  2000-05-19       Impact factor: 3.252

8.  Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies.

Authors:  L E Warner; P Mancias; I J Butler; C M McDonald; L Keppen; K G Koob; J R Lupski
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

9.  SRC-1 is involved in the control of the gene expression of myelin protein Po.

Authors:  Ilaria Teresa Rita Cavarretta; Luciano Martini; Marcella Motta; Carolyn Louise Smith; Roberto Cosimo Melcangi
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

10.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

View more
  14 in total

1.  Progesterone antagonist therapy in a Pelizaeus-Merzbacher mouse model.

Authors:  Thomas Prukop; Dirk B Epplen; Tobias Nientiedt; Sven P Wichert; Robert Fledrich; Ruth M Stassart; Moritz J Rossner; Julia M Edgar; Hauke B Werner; Klaus-Armin Nave; Michael W Sereda
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

2.  GABA-B1 Receptor-Null Schwann Cells Exhibit Compromised In Vitro Myelination.

Authors:  Alessandro Faroni; Simona Melfi; Luca Franco Castelnovo; Veronica Bonalume; Deborah Colleoni; Paolo Magni; Marcos J Araúzo-Bravo; Rolland Reinbold; Valerio Magnaghi
Journal:  Mol Neurobiol       Date:  2018-06-12       Impact factor: 5.590

3.  Membrane Progesterone Receptors (mPRs/PAQRs) Differently Regulate Migration, Proliferation, and Differentiation in Rat Schwann Cells.

Authors:  Luca F Castelnovo; Lucia Caffino; Veronica Bonalume; Fabio Fumagalli; Peter Thomas; Valerio Magnaghi
Journal:  J Mol Neurosci       Date:  2019-11-20       Impact factor: 3.444

4.  Regulation of the PMP22 gene through an intronic enhancer.

Authors:  Erin A Jones; Camila Lopez-Anido; Rajini Srinivasan; Courtney Krueger; Li-Wei Chang; Rakesh Nagarajan; John Svaren
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

5.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

6.  Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2.

Authors:  Lifei Liu; Junming Wang; Liqin Zhao; Jon Nilsen; Kelsey McClure; Karren Wong; Roberta Diaz Brinton
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

Review 7.  Progesterone receptors: form and function in brain.

Authors:  Roberta Diaz Brinton; Richard F Thompson; Michael R Foy; Michel Baudry; Junming Wang; Caleb E Finch; Todd E Morgan; Christian J Pike; Wendy J Mack; Frank Z Stanczyk; Jon Nilsen
Journal:  Front Neuroendocrinol       Date:  2008-02-23       Impact factor: 8.606

Review 8.  The molecular machinery of myelin gene transcription in Schwann cells.

Authors:  John Svaren; Dies Meijer
Journal:  Glia       Date:  2008-11-01       Impact factor: 8.073

9.  Role of neuroactive steroids in the peripheral nervous system.

Authors:  Roberto Cosimo Melcangi; Silvia Giatti; Marzia Pesaresi; Donato Calabrese; Nico Mitro; Donatella Caruso; Luis Miguel Garcia-Segura
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-27       Impact factor: 5.555

Review 10.  Regulating PMP22 expression as a dosage sensitive neuropathy gene.

Authors:  Harrison Pantera; Michael E Shy; John Svaren
Journal:  Brain Res       Date:  2019-10-03       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.